Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Open Access

Emerging biomarkers for cancer diagnosis: Paving the way for precision oncology

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMuhammad Zaid SalarUniversity of Agriculture FaisalabadGMGhulam MustafaJiangsu UniversityTHTaimur HassanAbu Dhabi University

Discussion

Loading...

Member takes

Implication

Analysis reveals advanced biomarkers enhance cancer detection in precision oncology, suggesting improved treatment methods.

Key Points

  • Emerging biomarkers improve cancer diagnosis and treatment, advancing the field of precision oncology.
  • Using techniques like liquid biopsy and metabolomic markers significantly enhances malignant detection.
  • Combining different biomarker methods can lead to more effective targeted therapies for cancer.
  • Sensitivity and stability issues with current biomarkers highlight the need for further research and innovation.

Cite This Study

Salar et al. (2025) studied this question.

synapsesocial.com/papers/68c1a40f54b1d3bfb60deaa3https://doi.org/10.63147/krjs.v4i2.148
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Emerging Biomarkers for Early Cancer Detection: Current Advances and Clinical Applications2026
  2. 2Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives2025 · 93 citations
  3. 3The Future of Cancer Diagnosis and Treatment: Unlocking the Power of Biomarkers and Personalized Molecular-Targeted Therapies2025 · 33 citations
  4. 4Bridging Discovery and Treatment: Cancer Biomarker2025
  5. 5Biomarkers as Drivers of Innovation in Modern Diagnostics and Therapeutics2026